These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11398801)

  • 1. The Health Care 250.
    Hoppszallern S
    Hosp Health Netw; 2001 May; 75(5):38-40, 42-4, 46-8. PubMed ID: 11398801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Health Care 250.
    Serb C
    Hosp Health Netw; 1999 Apr; 73(4):38-40, 42-4, 46-8. PubMed ID: 10224968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor quarterly showing. Big players' losses drag down healthcare earnings.
    Limbacher PB
    Mod Healthc; 1998 Apr; 28(14):36. PubMed ID: 10178295
    [No Abstract]   [Full Text] [Related]  

  • 4. Quarterly financial results of post acute/subacute companies.
    Natl Rep Subacute Care; 1998 Dec; 6(25):7-8. PubMed ID: 10338899
    [No Abstract]   [Full Text] [Related]  

  • 5. Boom vs. bust.
    Serb C
    Hosp Health Netw; 1999 Mar; 73(3):58-9, 2. PubMed ID: 10191735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. By the numbers. Drugs/purchasing.
    Mod Healthc; 2003 Dec; Suppl():22. PubMed ID: 14723068
    [No Abstract]   [Full Text] [Related]  

  • 7. Columbia woes hit sector in survey.
    Limbacher P
    Mod Healthc; 1997 Dec; 27(48):28. PubMed ID: 10174985
    [No Abstract]   [Full Text] [Related]  

  • 8. High on health care.
    Serb C
    Hosp Health Netw; 1999 Feb; 73(2):28. PubMed ID: 10081450
    [No Abstract]   [Full Text] [Related]  

  • 9. By the numbers. Top 20 pharmaceutical companies. Ranked by U.S. sales, April 2003 through March 2004.
    Moon S
    Mod Healthc; 2004 Aug; 34(33):40. PubMed ID: 15356990
    [No Abstract]   [Full Text] [Related]  

  • 10. Providers post solid earnings growth.
    Lutz S
    Mod Healthc; 1995 Nov; 25(48):6. PubMed ID: 10152693
    [No Abstract]   [Full Text] [Related]  

  • 11. Top stocks.
    Hosp Health Netw; 1997 Apr; 71(8):36, 38. PubMed ID: 9133874
    [No Abstract]   [Full Text] [Related]  

  • 12. 2002 Benchmarking Guide.
    Hoppszallern S
    Hosp Health Netw; 2002 Feb; 76(2):33-9, 2. PubMed ID: 11912987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of data on the health sector of the United States January 2002.
    Hellander I
    Int J Health Serv; 2002; 32(3):579-99. PubMed ID: 12211294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fiscal 1998 annual financial results of post acute/subacute companies.
    Natl Rep Subacute Care; 1999 Mar; 7(6):7. PubMed ID: 10387723
    [No Abstract]   [Full Text] [Related]  

  • 15. Options analysis of managed care contracting and regulation: theory and evidence.
    McLean RA; Magiera FT
    Health Serv Manage Res; 2000 Aug; 13(3):170-7. PubMed ID: 11184019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A healthy merger? A big deal makes Aetna the country's largest health-care company.
    Smolowe J
    Time; 1996 Apr; 147(16):77-8. PubMed ID: 10156010
    [No Abstract]   [Full Text] [Related]  

  • 18. Redistribution of risk throughout the pharmaceutical industry.
    Scheur BS
    Med Interface; 1994 Oct; 7(10):77-80. PubMed ID: 10137569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fortune 1,000 ranked within industries.
    Fortune; 1997 Apr; 135(8):F44-70. PubMed ID: 10166669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenet faults managed care for earnings disappointment.
    Lutz S
    Mod Healthc; 1995 Jul; 25(31):2. PubMed ID: 10144312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.